Sid E O'Bryant1, Melissa Petersen1,2, James Hall1, Leigh Johnson1. 1. Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX, USA. 2. Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA.
Abstract
BACKGROUND: Despite the tremendous amount of research on Alzheimer's disease (AD) biomarkers, very little data is available regarding the fundamental biomarkers of AD among Mexican Americans. OBJECTIVE: Here we sought to examine the link between metabolic markers and brain amyloid among Mexican Americans as compared to non-Hispanic whites from the Health & Aging Brain Study -Health Disparities (HABS-HD) cohort. METHODS: PET amyloid (florbetaben) data was analyzed from 34 Mexican American and 22 non-Hispanic white participants. RESULTS: Glucagon (t = 3.84, p < 0.001) and insulin (t = -2.56, p = 0.02) were both significantly related to global SUVR levels among Mexican Americans. Glucagon and insulin were both related to most ROIs. No metabolic markers were significantly related to brain amyloid levels among non-Hispanic whites. CONCLUSION: Metabolic markers are related to brain amyloid burden among Mexican Americans. Given the increased risk for diabetes, additional research is needed to determine the impact of diabetes on core AD biomarkers among this underserved population.
BACKGROUND: Despite the tremendous amount of research on Alzheimer's disease (AD) biomarkers, very little data is available regarding the fundamental biomarkers of AD among Mexican Americans. OBJECTIVE: Here we sought to examine the link between metabolic markers and brain amyloid among Mexican Americans as compared to non-Hispanic whites from the Health & Aging Brain Study -Health Disparities (HABS-HD) cohort. METHODS: PET amyloid (florbetaben) data was analyzed from 34 Mexican American and 22 non-Hispanic white participants. RESULTS: Glucagon (t = 3.84, p < 0.001) and insulin (t = -2.56, p = 0.02) were both significantly related to global SUVR levels among Mexican Americans. Glucagon and insulin were both related to most ROIs. No metabolic markers were significantly related to brain amyloid levels among non-Hispanic whites. CONCLUSION: Metabolic markers are related to brain amyloid burden among Mexican Americans. Given the increased risk for diabetes, additional research is needed to determine the impact of diabetes on core AD biomarkers among this underserved population.
Entities:
Keywords:
Alzheimer’s disease; Hispanic; amyloid; health disparities
Authors: Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant Journal: Alzheimers Dement Date: 2018-12-13 Impact factor: 21.566
Authors: Sid E O'Bryant; Leigh Johnson; Joan Reisch; Melissa Edwards; James Hall; Robert Barber; Michael D Devous; Donald Royall; Meharvan Singh Journal: Alzheimers Dement Date: 2013-05-02 Impact factor: 21.566
Authors: Joan Lindsay; Danielle Laurin; René Verreault; Réjean Hébert; Barbara Helliwell; Gerry B Hill; Ian McDowell Journal: Am J Epidemiol Date: 2002-09-01 Impact factor: 4.897
Authors: Sid E O'Bryant; Fan Zhang; Melissa Petersen; Leigh Johnson; James Hall; Robert A Rissman Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Keenan A Walker; Noah Silverstein; Yun Zhou; Timothy M Hughes; Clifford R Jack; David S Knopman; A Richey Sharrett; Dean F Wong; Thomas H Mosley; Rebecca F Gottesman Journal: J Am Heart Assoc Date: 2021-08-25 Impact factor: 5.501
Authors: Sid E O'Bryant; Leigh A Johnson; Robert C Barber; Meredith N Braskie; Bradley Christian; James R Hall; Nalini Hazra; Kevin King; Deydeep Kothapalli; Stephanie Large; David Mason; Elizabeth Matsiyevskiy; Roderick McColl; Rajesh Nandy; Raymond Palmer; Melissa Petersen; Nicole Philips; Robert A Rissman; Yonggang Shi; Arthur W Toga; Raul Vintimilla; Rocky Vig; Fan Zhang; Kristine Yaffe Journal: Alzheimers Dement (Amst) Date: 2021-06-21